Can we predict who will relapse after brain inflammation?

NCT ID NCT07722286

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study examines a rare brain disease called anti-LGI1 encephalitis, where the immune system attacks a protein in the brain, causing memory loss, confusion, and seizures. Researchers will review medical records from 112 patients across five hospitals in Eastern China to see how often the disease returns or causes lasting problems. The goal is to identify factors that raise the risk of relapse or poor recovery, which could lead to better long-term care strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors identify which patients need closer monitoring and longer treatment to prevent relapses and improve long-term quality of life.
What could go wrong
This is an observational study looking back at medical records, so it cannot prove cause and effect. Results may not apply to all patients with this rare condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOIMMUNE ENCEPHALITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

    Hangzhou, Zhejiang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.